Priyardhisini Nagarajan

41PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesMolecular targetsTe mana tāne (male status)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 25, 2025
Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma.

David Z Allen, Neil Gross, Marc-Elie Nader

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

|Jan 06, 2025
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes.

Erol Can Bayraktar, Phyu P Aung, Pavandeep Gill

|Jul 25, 2024
Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the BRAF p.V600E Mutation in a Subset of Cases.

Feifan Chen, Priyadharsini Nagarajan, Phyu P Aung

|Mar 06, 2024
Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review.

Haneen T Salah, Richard K Yang, Sinchita Roy-Chowdhuri

|Jan 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.

Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan

Pageof 7